Sempra (SRE) Stock Price & Analysis
Sempra (SRE) closed at USD 84.77 on Thursday, October 22, 2026, up 1.52% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 83.5; the Oct 22, 2026 session ranged USD 83.59–84.98 on volume of 2,797,787 shares. Market capitalization is $55.43B, with a 52-week range of USD 76.21–101.04 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SRE.md
Key facts (SRE)
- Last four reported quarters (through Jun 30, 2026): revenue $13.5B, net income $2.28B (16.8% margin), free cash flow -$5.24B (SEC filings).
- Valuation: P/E 24.3x (avg 22.1x at the last 3 fiscal year-ends), net debt $34.5B.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (21 analysts), mean target USD 97.42 (range 83–118).
- Total return with dividends: 1Y -4.9% vs S&P 500 +14.9%; 5Y +51.2% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.21, revenue estimate $3.31B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (SRE)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $12.9B | $14.4B | $16.7B | $13.2B | $13.7B | $13.5B |
| Net income | $1.32B | $2.14B | $3.08B | $2.86B | $1.84B | $2.28B |
| EPS (diluted) | $2.01 | $3.31 | $4.79 | $4.42 | $2.75 | — |
| Free cash flow | -$1.17B | -$4.21B | -$2.18B | -$3.31B | -$6.05B | -$5.24B |
| Net margin | 10.3% | 14.8% | 18.4% | 21.7% | 13.4% | 16.8% |
| Revenue growth | +13.1% | +12.3% | +15.8% | -21.1% | +3.9% | — |
| Cash + short-term investments | $559M | $370M | $236M | $1.56B | $29.0M | — |
| Total debt | $24.5B | $27.9B | $30.1B | $33.6B | $33.1B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SRE)
P/E 24.3x · P/S 4.1x · EV/Sales 6.6x · P/B 1.7x · FCF yield -9.46% · Earnings yield 4.12% · Dividend yield (paid, TTM) 2.96% · Buyback yield (TTM) 0.04% · Net debt $34.5B · EV $90.0B
P/E at fiscal year-ends: Dec 2025 31.4x, Dec 2024 19.6x, Dec 2023 15.4x.
Analysts (SRE)
Consensus Buy (mean 2.00 on a 1–5 scale), 21 analysts; mean target USD 97.42 (low 83, high 118).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | HSBC | Initiated | Buy | $97.5 |
| 2026-10-14 | Truist Securities | Target lowered | Buy | $96 → $94 |
| 2026-10-12 | Barclays | Target lowered | Overweight | $103 → $90 |
| 2026-10-12 | JP Morgan | Target lowered | Overweight | $102 → $99 |
| 2026-09-29 | Scotiabank | Initiated | Sector Perform | $83 |
| 2026-09-18 | Morgan Stanley | Target lowered | Overweight | $104 → $100 |
| 2026-09-03 | Truist Securities | Target lowered | Buy | $100 → $96 |
| 2026-09-02 | JP Morgan | Target lowered | Overweight | $113 → $102 |
| 2026-09-01 | Jefferies | Upgrade | Hold → Buy | $101 → $97 |
| 2026-08-31 | Mizuho | Downgrade | Outperform → Neutral | $104 → $84 |
| 2026-08-21 | Morgan Stanley | Target lowered | Overweight | $108 → $104 |
| 2026-08-13 | Truist Securities | Target lowered | Buy | $107 → $100 |
Total return (dividends reinvested) (SRE)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -4.9% | +51.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -4.9% | +8.6% |
| Volatility (annualized) | 20.4% | 23.5% |
| Max drawdown | -21.7% (Apr 2026→Sep 2026) | -29.0% (Nov 2024→Mar 2025) |
SRE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.21 | $1.00 | +20.9% | $3.31B | 14 |
| Next quarter (ends Dec 2026) | $1.25 | $1.55 | -19.4% | $3.89B | 11 |
| Current fiscal year (ends Dec 2026) | $5.13 | $5.11 | +0.4% | $13.81B | 17 |
| Next fiscal year (ends Dec 2027) | $5.54 | $5.54 | +0.0% | $13.79B | 18 |
Key Statistics (as of October 23, 2026 at 10:12 UTC)
| Price | USD 84.77 |
|---|---|
| Change | ▲ 1.52% (up) |
| Previous Close | USD 83.5 |
| Open | USD 83.81 |
| Day Range | USD 83.59 – 84.98 |
| 52-Week Range | USD 76.21 – 101.04 |
| Volume | 2,797,787 shares |
| Market Cap | $55.43B |
| Exchange | NYQ |
Technical Analysis (SRE)
Nexqual's technical model rates SRE "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 10:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.76 (neutral) |
| vs SMA50 | Above (USD 82.41) |
| MACD | 0.48 (positive) |
Analyst Ratings (SRE)
Wall Street analysts rate SRE "Buy" based on 21 analysts, with a mean price target of USD 97.42 (range USD 83–118), per Nexqual as of October 23, 2026 at 10:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 97.42 |
| High Target | USD 118 |
| Low Target | USD 83 |
| Buy / Hold / Sell | 17 / 4 / 0 |
Earnings (SRE)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 1.21 |
| Revenue Estimate | $3.31B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.16 vs est 1.06 ▲ beat |
| 2026-03-31 | USD 1.51 vs est 1.51 ▼ miss |
| 2025-12-31 | USD 1.28 vs est 1.17 ▲ beat |
| 2025-09-30 | USD 1.11 vs est 0.91 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financials & Fundamentals (SRE)
| Total Revenue | $13.55B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -0.10% |
| Gross Margin | +43.99% |
| Operating Margin | +28.33% |
| Profit Margin | +16.82% |
| ROE | +6.68% |
| Debt / Equity | 0.85 |
| Current Ratio | 1.64 |
| Total Cash | $48.00M |
| Total Debt | $36.66B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$5.24B (-38.7% of revenue) |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financial Health Score (SRE)
Nexqual rates Sempra's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:12 UTC.
| Growth | Mixed — Revenue +3.9% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 28% (last 12 months) |
| Balance Sheet | Mixed — $48M cash and investments vs $34.6B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$5.24B (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — ROE 7%, ROA 2.0% |
Ownership (SRE)
| Insider Ownership | +0.10% |
|---|---|
| Institutional Ownership | +93.88% |
| Shares Outstanding | 653.90M |
| Float | 652.55M |
| Short % of Float | +2.31% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Leadership (SRE)
Sempra is led by Jeffrey Walker Martin, Chairman, President & CEO, per Nexqual as of October 23, 2026 at 10:12 UTC.
| Chairman, President & CEO | Jeffrey Walker Martin |
|---|---|
| Executive VP & CFO | Karen L. Sedgwick |
| Executive Vice President | Caroline A. Winn |
| Vice President of Investor Relations | Louise Bick |
| Senior Vice President of Corporate Development | Sandeep K. Mor |
Major Backers & Investors (SRE)
Notable institutional backers of Sempra include Wellington Management, Morgan Stanley, JPMorgan, according to Nexqual as of October 23, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 6.7% |
| Morgan Stanley | 3.83% |
| JPMorgan | 3.07% |
| FMR, LLC | 2.98% |
| Capital International Investors | 2.22% |
| SELECT SECTOR SPDR TRUST-State Street Utilities Select Sector SPDR ETF | 1.77% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.24% |
| BlackRock | 9.22% |
| State Street | 5.81% |
| Geode Capital | 2.39% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIP | Brookfield Infrastructure Partn | USD 37.29 | ▲ 2.53% |
| AES | The AES Corporation | USD 14.97 | ▼ 0% |
| AQN | Algonquin Power & Utilities Cor | USD 5.45 | ▲ 2.64% |
| AVA | Avista Corporation | USD 37.74 | ▲ 2.22% |
| UTL | UNITIL Corporation | USD 55.06 | ▲ 2.76% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt